<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/DD567D99-893B-43CA-B141-0C6A3D481748"><gtr:id>DD567D99-893B-43CA-B141-0C6A3D481748</gtr:id><gtr:name>School of Medicine</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2F245DA4-C96D-490A-8414-23EFD81F3D3C"><gtr:id>2F245DA4-C96D-490A-8414-23EFD81F3D3C</gtr:id><gtr:name>Beijing University</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>College of Medical, Veterinary &amp;Life Sci</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/DD567D99-893B-43CA-B141-0C6A3D481748"><gtr:id>DD567D99-893B-43CA-B141-0C6A3D481748</gtr:id><gtr:name>School of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2F245DA4-C96D-490A-8414-23EFD81F3D3C"><gtr:id>2F245DA4-C96D-490A-8414-23EFD81F3D3C</gtr:id><gtr:name>Beijing University</gtr:name><gtr:address><gtr:line1>Administration</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/493C9CF6-25CA-4B16-B4D0-6BE837F99150"><gtr:id>493C9CF6-25CA-4B16-B4D0-6BE837F99150</gtr:id><gtr:firstName>Damo</gtr:firstName><gtr:surname>Xu</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/2D6F6946-D55B-43F7-A0F5-D4556B5B4D86"><gtr:id>2D6F6946-D55B-43F7-A0F5-D4556B5B4D86</gtr:id><gtr:firstName>Foo</gtr:firstName><gtr:otherNames>Yew</gtr:otherNames><gtr:surname>Liew</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G9818261"><gtr:id>65516464-5020-4913-9599-7A969EB2E6A4</gtr:id><gtr:title>Toll-like Receptors on T cells</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9818261</gtr:grantReference><gtr:abstractText>Results obtained will be communicated by peer reviewed publications. In additon, the key information will be publicised through scientific and media conferences.During public presentations it will be emphasized that the programme addresses a fundamental issue of our defence against infection and the control of self-destructive inflammatory diseases. The principles to be uncovered by the programme, which is based on our ongoing novel discovery carried out under the current MRC programme grant, will have far reaching implications not only in fundamental science but also in the practical applications in treating some of the most important human diseases. These include new methods for vaccine development and suppressing destructive inflammation such as rheumatoid arthritis and asthma. We will concentrate on uncovering the mechanisms by which bacterial lipoprotein (BLP) can synergise with specific antigens to activate T lymphocytes (T cells) and maintain the life span of these cells, the memory T cells. T cells play a pivotal role in orchestrating the immune response and the ability to regulate their functions is crucial in enhancing the host response to pathogens and controlling excessive immune response which could be detrimental to the host. For example, if we know exactly how we can produce an enhanced T cell response and sustain T cell memory when encountering the bacterial product BLP, then we could design a method to boost our response to the infection to produce a better vaccine. On the other hand, when dealing with the infection, there is a danger that the host may produce excessive response to BLP and cause self-destructive inflammation. We have now found that another molecule called ST2, present on T cells, can down-regulate the signal produced by BLP. If we understand precisely how this works, we may be able to devise new methods to control the excessive inflammatory response. Thus, the programme holds considerable promise in finding novel approaches to combat infectious and autoimmune diseases.</gtr:abstractText><gtr:technicalSummary>The immune system evolved to combat pathogens and to avoid autoimmune disease. This is achieved through innate and adaptive immune response, together with a tight regulatory network involving regulatory T cells. Work carried out under the current MRC programme grant has unravelled an important novel mechanism through which this immune homeostasis may be achieved. We found that human and mouse T cells expressed functional Toll-like receptor (TLR) 2 when activated through the T cell receptor. TLR2 functions as a co-receptor for activated and memory T cells and may help to maintain long-term T cell memory. Furthermore, in preliminary experiments, we also found that TLR2 ligand, the highly conserved bacterial lipoprotein (BLP), could also enhance the expansion of CD4+CD25+ regulatory T (Treg) cells, thus representing a potentially important self-regulatory mechanism. We have also discovered that the orphan receptor, ST2, a member of the Toll-IL-1R super-family, could negatively regulate the IL-1R and TLR2 signalling in macrophages, thus forming an additional control mechanism to prevent over stimulation of the immune system via the TLR system. We now propose to carry out in-depth investigations into the function of TLR2 on T cells arising from these initial findings. (1) To study the role of TLR2 in the generation and maintenance of T cell memory in vivo. (2) To determine the role of TLR2 in the function of CD4+CD25+ Treg cells. (3) To analyse the role of ST2 in TLR2 functions on T cells. (4) To explore the clinical relevance of TLR2 and its regulation by ST2 and CD4+CD25+ Treg cells. We will employ the latest technologies in gene targeting, cellular immunology and molecular biology to address these questions, and also use clinical samples from inflammatory diseases, including asthma and rheumatoid arthritis, in which we have considerable experience and collaborative track record. It is hope that this series of studies will not only advance our knowledge in fundamental immunology, such as how the pathogen-associated molecular recognition patterns directly influence T cell immunity, but also lead to novel therapeutic opportunities against infectious and inflammatory diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2009-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-03-16</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2848025</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Beijing</gtr:collaboratingOrganisation><gtr:country>China, People's Republic of</gtr:country><gtr:description>Collaboration with the Beijing University to develop IL-35 and IL-37 transgenic mice</gtr:description><gtr:id>92CFBECF-86E4-4252-B0F3-92915C96A6F6</gtr:id><gtr:impact>Not yet</gtr:impact><gtr:partnerContribution>Potentially, we can expand our research using the transgenic mice constructed by this collaborator</gtr:partnerContribution><gtr:piContribution>Initiate the project</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>School of Medicine</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Pharmacology</gtr:department><gtr:description>There have been extensive collaborations with many individuals and Research Institutes within University of Glasgow and outside the University.</gtr:description><gtr:id>031926F0-3E29-4910-8A09-76B3D6CA0007</gtr:id><gtr:impact>There has been many publications resulted from these collaborations</gtr:impact><gtr:partnerContribution>Joint experiments that have resulted in important publications</gtr:partnerContribution><gtr:piContribution>University of Sao Paulo, University of United Arab Emirates</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>99BCDDB2-45D4-45CA-961D-9C9BABF9820A</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Programme Grant (The ST2 receptor system in health and disease)</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:id>17DB13F2-0444-473B-9A83-7CA11DD9727D</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>750000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>A1064D0A-0003-473D-9669-E07E938B0F7E</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>250000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Commission, collaborative grant</gtr:description><gtr:end>2011-10-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:id>70A6CDBA-132B-48F9-86AA-A149B6274BC6</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DF8F0D12-A32C-4EC8-9E0A-5944D09A86D3"><gtr:id>DF8F0D12-A32C-4EC8-9E0A-5944D09A86D3</gtr:id><gtr:title>IL-33 mediates antigen-induced cutaneous and articular hypernociception in mice.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b16629f7643a0249636b4dc0eb514bb4"><gtr:id>b16629f7643a0249636b4dc0eb514bb4</gtr:id><gtr:otherNames>Verri WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B11482F-A0FC-401C-8612-7EBE5BF8F28F"><gtr:id>2B11482F-A0FC-401C-8612-7EBE5BF8F28F</gtr:id><gtr:title>Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+ T cells at heart lesions of human chronic Chagas disease cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Scandinavian journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7660f655b1287e1b234fcaff749c08b8"><gtr:id>7660f655b1287e1b234fcaff749c08b8</gtr:id><gtr:otherNames>Fonseca SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-9475</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BC043421-0E8E-4510-B40D-DBB72DE5F7F2"><gtr:id>BC043421-0E8E-4510-B40D-DBB72DE5F7F2</gtr:id><gtr:title>Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b9b8f6134f2dda035c13e759d60eac1e"><gtr:id>b9b8f6134f2dda035c13e759d60eac1e</gtr:id><gtr:otherNames>Liu H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FD92B278-116F-4357-A1D3-CA8BC5082912"><gtr:id>FD92B278-116F-4357-A1D3-CA8BC5082912</gtr:id><gtr:title>Host-response: understanding the cellular and molecular mechanisms of host-microbial interactions--consensus of the Seventh European Workshop on Periodontology.</gtr:title><gtr:parentPublicationTitle>Journal of clinical periodontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/659360bec0ab428cd6ce9f5ded5d69da"><gtr:id>659360bec0ab428cd6ce9f5ded5d69da</gtr:id><gtr:otherNames>Kinane DF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0303-6979</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EFC61602-3975-4FAB-9B12-3F4880697319"><gtr:id>EFC61602-3975-4FAB-9B12-3F4880697319</gtr:id><gtr:title>Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ca52db21e71dca00b7f92f38da2e47e"><gtr:id>8ca52db21e71dca00b7f92f38da2e47e</gtr:id><gtr:otherNames>McKimmie CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FF93CB07-7EC0-4F5F-9896-9614E5DEA944"><gtr:id>FF93CB07-7EC0-4F5F-9896-9614E5DEA944</gtr:id><gtr:title>IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory T cells.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2c22e6fb93d0886d90a7f8335ccf26a0"><gtr:id>2c22e6fb93d0886d90a7f8335ccf26a0</gtr:id><gtr:otherNames>Besnard AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9A7EDC6D-CA7C-4FB9-AB9F-E14DA580DFCB"><gtr:id>9A7EDC6D-CA7C-4FB9-AB9F-E14DA580DFCB</gtr:id><gtr:title>Interleukin 27 attenuates collagen-induced arthritis.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27d6c70628e2e918f4cbee0dcadac415"><gtr:id>27d6c70628e2e918f4cbee0dcadac415</gtr:id><gtr:otherNames>Niedbala W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2630997C-5B86-42DF-BD7D-DCDFC73BFE4E"><gtr:id>2630997C-5B86-42DF-BD7D-DCDFC73BFE4E</gtr:id><gtr:title>Role of IL-18 in overt pain-like behaviour in mice.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b16629f7643a0249636b4dc0eb514bb4"><gtr:id>b16629f7643a0249636b4dc0eb514bb4</gtr:id><gtr:otherNames>Verri WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5835D287-DEF1-4808-931C-D3C279B2DB63"><gtr:id>5835D287-DEF1-4808-931C-D3C279B2DB63</gtr:id><gtr:title>ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9ce0bb5b53cb2e114121752978702e88"><gtr:id>9ce0bb5b53cb2e114121752978702e88</gtr:id><gtr:otherNames>Fagundes CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DA25228B-B438-43BE-83B0-CF37A0128535"><gtr:id>DA25228B-B438-43BE-83B0-CF37A0128535</gtr:id><gtr:title>IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mammalian target of rapamycin.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/181788d1197fdc4cae30985077b49b51"><gtr:id>181788d1197fdc4cae30985077b49b51</gtr:id><gtr:otherNames>Salmond RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7219A17C-B744-4CD9-83CC-777C0F72B96B"><gtr:id>7219A17C-B744-4CD9-83CC-777C0F72B96B</gtr:id><gtr:title>The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3d0729b1b2fbb5a4d15e19c73abc497f"><gtr:id>3d0729b1b2fbb5a4d15e19c73abc497f</gtr:id><gtr:otherNames>Sesti-Costa R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C2678C40-788E-4172-8A23-70A058213A8C"><gtr:id>C2678C40-788E-4172-8A23-70A058213A8C</gtr:id><gtr:title>Antigen-induced inflammatory mechanical hypernociception in mice is mediated by IL-18.</gtr:title><gtr:parentPublicationTitle>Brain, behavior, and immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b16629f7643a0249636b4dc0eb514bb4"><gtr:id>b16629f7643a0249636b4dc0eb514bb4</gtr:id><gtr:otherNames>Verri WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0889-1591</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DA06986D-CC9C-46CF-AD96-6361A6C3BF5F"><gtr:id>DA06986D-CC9C-46CF-AD96-6361A6C3BF5F</gtr:id><gtr:title>IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/575fe53874a5674190be0b00b681e5ab"><gtr:id>575fe53874a5674190be0b00b681e5ab</gtr:id><gtr:otherNames>Zaiss MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BE25F6F4-26DE-43C7-96FF-620F2538DD4C"><gtr:id>BE25F6F4-26DE-43C7-96FF-620F2538DD4C</gtr:id><gtr:title>Regulation of type 17 helper T-cell function by nitric oxide during inflammation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27d6c70628e2e918f4cbee0dcadac415"><gtr:id>27d6c70628e2e918f4cbee0dcadac415</gtr:id><gtr:otherNames>Niedbala W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0A580126-1EDD-4C27-A662-33423D1D6D0C"><gtr:id>0A580126-1EDD-4C27-A662-33423D1D6D0C</gtr:id><gtr:title>Immunological mechanisms and clinical implications of regulatory T cell deficiency in a systemic autoimmune disorder: roles of IL-2 versus IL-15.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/66e55afa75dfc7d5c2db77933d53682c"><gtr:id>66e55afa75dfc7d5c2db77933d53682c</gtr:id><gtr:otherNames>Yang CH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82112BBD-BBD9-4C7E-A624-96DB09E6E553"><gtr:id>82112BBD-BBD9-4C7E-A624-96DB09E6E553</gtr:id><gtr:title>TLR9-independent effects of inhibitory oligonucleotides on macrophage responses to S. typhimurium.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0bfc2f1098958f434a6850f39a3c07f4"><gtr:id>0bfc2f1098958f434a6850f39a3c07f4</gtr:id><gtr:otherNames>Trieu A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/80577DA0-7945-4B86-9994-DE34A330C7E5"><gtr:id>80577DA0-7945-4B86-9994-DE34A330C7E5</gtr:id><gtr:title>IL-33 induces skin inflammation with mast cell and neutrophil activation.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/886abf362db80f502c90ad76ccc80c2e"><gtr:id>886abf362db80f502c90ad76ccc80c2e</gtr:id><gtr:otherNames>Hueber AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2F5C2E3C-B9A2-46F7-85A7-5C11D901C308"><gtr:id>2F5C2E3C-B9A2-46F7-85A7-5C11D901C308</gtr:id><gtr:title>Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/63e638ecaaad0ff3875bc715972a1fc2"><gtr:id>63e638ecaaad0ff3875bc715972a1fc2</gtr:id><gtr:otherNames>Komai-Koma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/386A60A9-B950-4D6D-8C44-8835C8EF7F7A"><gtr:id>386A60A9-B950-4D6D-8C44-8835C8EF7F7A</gtr:id><gtr:title>IL-33, a potent inducer of adaptive immunity to intestinal nematodes.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ccaabb571eb4e9222a477ea35a2d7d9d"><gtr:id>ccaabb571eb4e9222a477ea35a2d7d9d</gtr:id><gtr:otherNames>Humphreys NE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C24DB333-8671-47DB-93CE-2E5497A32BF1"><gtr:id>C24DB333-8671-47DB-93CE-2E5497A32BF1</gtr:id><gtr:title>CXCR2-specific chemokines mediate leukotriene B4-dependent recruitment of neutrophils to inflamed joints in mice with antigen-induced arthritis.</gtr:title><gtr:parentPublicationTitle>Arthritis and rheumatism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a2502a8b0dccd8fbf755f5604c236841"><gtr:id>a2502a8b0dccd8fbf755f5604c236841</gtr:id><gtr:otherNames>Grespan R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0004-3591</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4402B0C5-6FB4-45AD-8093-3CCF055736C3"><gtr:id>4402B0C5-6FB4-45AD-8093-3CCF055736C3</gtr:id><gtr:title>TLR1/TLR2 agonist induces tumor regression by reciprocal modulation of effector and regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d895db59e431e55ec84105d0da4fab0d"><gtr:id>d895db59e431e55ec84105d0da4fab0d</gtr:id><gtr:otherNames>Zhang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4472D6C5-E3D7-4804-87A3-1CDECC68FA8E"><gtr:id>4472D6C5-E3D7-4804-87A3-1CDECC68FA8E</gtr:id><gtr:title>Role of nitric oxide in the regulation of T cell functions.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27d6c70628e2e918f4cbee0dcadac415"><gtr:id>27d6c70628e2e918f4cbee0dcadac415</gtr:id><gtr:otherNames>Niedbala W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8878987D-1648-4A19-B8DB-8EDCCB292F97"><gtr:id>8878987D-1648-4A19-B8DB-8EDCCB292F97</gtr:id><gtr:title>IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d6382940be00966049fbb664f03fba32"><gtr:id>d6382940be00966049fbb664f03fba32</gtr:id><gtr:otherNames>Turnquist HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3F26F282-0512-4196-BC1B-53B44445002E"><gtr:id>3F26F282-0512-4196-BC1B-53B44445002E</gtr:id><gtr:title>IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b16629f7643a0249636b4dc0eb514bb4"><gtr:id>b16629f7643a0249636b4dc0eb514bb4</gtr:id><gtr:otherNames>Verri WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D02637C4-367F-4FE2-84FC-07B61B5B08B9"><gtr:id>D02637C4-367F-4FE2-84FC-07B61B5B08B9</gtr:id><gtr:title>Interleukin-33 and the function of innate lymphoid cells.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/76a9c296c0e07da4d0fb0e98d30823d5"><gtr:id>76a9c296c0e07da4d0fb0e98d30823d5</gtr:id><gtr:otherNames>Mirchandani AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/58313A92-02F9-417F-BCCF-4AEE98864670"><gtr:id>58313A92-02F9-417F-BCCF-4AEE98864670</gtr:id><gtr:title>Animal models of rheumatoid arthritis.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a8c81b946dab25d016d4ae274f7b8944"><gtr:id>a8c81b946dab25d016d4ae274f7b8944</gtr:id><gtr:otherNames>Asquith DL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FEE7D635-0819-4F40-8509-9024CA99285C"><gtr:id>FEE7D635-0819-4F40-8509-9024CA99285C</gtr:id><gtr:title>IL-33: a Janus cytokine.</gtr:title><gtr:parentPublicationTitle>Annals of the rheumatic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d903f48e79964a5d02e098b694a592d"><gtr:id>0d903f48e79964a5d02e098b694a592d</gtr:id><gtr:otherNames>Liew FY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0003-4967</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A5ED4241-94DF-4C7F-BB5E-5FEE892B6519"><gtr:id>A5ED4241-94DF-4C7F-BB5E-5FEE892B6519</gtr:id><gtr:title>IL-33 attenuates EAE by suppressing IL-17 and IFN-? production and inducing alternatively activated macrophages.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2a2fc1758d2867fc19fb4fd882fa28f"><gtr:id>f2a2fc1758d2867fc19fb4fd882fa28f</gtr:id><gtr:otherNames>Jiang HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0BB50AE8-6825-4F5C-A56A-29620C38566F"><gtr:id>0BB50AE8-6825-4F5C-A56A-29620C38566F</gtr:id><gtr:title>MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c46e2ecdbdcf081c5e7884ac05702bb5"><gtr:id>c46e2ecdbdcf081c5e7884ac05702bb5</gtr:id><gtr:otherNames>Kurowska-Stolarska M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/19785BBF-94A8-4A16-968F-58F7BB242907"><gtr:id>19785BBF-94A8-4A16-968F-58F7BB242907</gtr:id><gtr:title>IL-33 exacerbates autoantibody-induced arthritis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e8d926f151e1a5ca9c91291369227789"><gtr:id>e8d926f151e1a5ca9c91291369227789</gtr:id><gtr:otherNames>Xu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/652371EA-8251-49A1-9AF1-EB224664B553"><gtr:id>652371EA-8251-49A1-9AF1-EB224664B553</gtr:id><gtr:title>What can the periodontal community learn from the pathophysiology of rheumatoid arthritis?</gtr:title><gtr:parentPublicationTitle>Journal of clinical periodontology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d824e354badbb295816a45a36878f1f8"><gtr:id>d824e354badbb295816a45a36878f1f8</gtr:id><gtr:otherNames>Culshaw S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0303-6979</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EFC21230-E52D-47F1-AE83-90E3CF3D6D05"><gtr:id>EFC21230-E52D-47F1-AE83-90E3CF3D6D05</gtr:id><gtr:title>Prostaglandin mediates IL-23/IL-17-induced neutrophil migration in inflammation by inhibiting IL-12 and IFNgamma production.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cf5399a7d50fc64e4536fee66c538aec"><gtr:id>cf5399a7d50fc64e4536fee66c538aec</gtr:id><gtr:otherNames>Lemos HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/21CAAF91-E347-45E0-BBB7-B2E9C0DB7E0B"><gtr:id>21CAAF91-E347-45E0-BBB7-B2E9C0DB7E0B</gtr:id><gtr:title>IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c46e2ecdbdcf081c5e7884ac05702bb5"><gtr:id>c46e2ecdbdcf081c5e7884ac05702bb5</gtr:id><gtr:otherNames>Kurowska-Stolarska M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CBCDAA52-A959-401C-9BB4-B5D1D70D7BEB"><gtr:id>CBCDAA52-A959-401C-9BB4-B5D1D70D7BEB</gtr:id><gtr:title>Novel allergic asthma model demonstrates ST2-dependent dendritic cell targeting by cypress pollen.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2bf4678bffdcb0cafd313bbf3b4880bb"><gtr:id>2bf4678bffdcb0cafd313bbf3b4880bb</gtr:id><gtr:otherNames>Gabriele L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/782C80EC-C4AE-4D09-A763-83B07F6D45C6"><gtr:id>782C80EC-C4AE-4D09-A763-83B07F6D45C6</gtr:id><gtr:title>IL-33 reduces the development of atherosclerosis.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fdcdecde1e6b0fc0dca13d046b13fffe"><gtr:id>fdcdecde1e6b0fc0dca13d046b13fffe</gtr:id><gtr:otherNames>Miller AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/43FAB774-DDDE-48CD-88D8-65E0FB9A47B5"><gtr:id>43FAB774-DDDE-48CD-88D8-65E0FB9A47B5</gtr:id><gtr:title>Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in na&amp;iuml;ve mice.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/63e638ecaaad0ff3875bc715972a1fc2"><gtr:id>63e638ecaaad0ff3875bc715972a1fc2</gtr:id><gtr:otherNames>Komai-Koma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC194076-1B91-47FA-A733-1081680DF909"><gtr:id>FC194076-1B91-47FA-A733-1081680DF909</gtr:id><gtr:title>Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ca52db21e71dca00b7f92f38da2e47e"><gtr:id>8ca52db21e71dca00b7f92f38da2e47e</gtr:id><gtr:otherNames>McKimmie CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CDF121CE-C2C1-4F34-ACE2-863449323E9C"><gtr:id>CDF121CE-C2C1-4F34-ACE2-863449323E9C</gtr:id><gtr:title>Expression and alternative processing of IL-18 in human neutrophils.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/64d2404d09f5d7d3bfc3ce4065a61f48"><gtr:id>64d2404d09f5d7d3bfc3ce4065a61f48</gtr:id><gtr:otherNames>Robertson SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C68BB721-4E07-4082-A686-E31A72515708"><gtr:id>C68BB721-4E07-4082-A686-E31A72515708</gtr:id><gtr:title>Nitric oxide-induced regulatory T cells inhibit Th17 but not Th1 cell differentiation and function.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27d6c70628e2e918f4cbee0dcadac415"><gtr:id>27d6c70628e2e918f4cbee0dcadac415</gtr:id><gtr:otherNames>Niedbala W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E2B51889-99D4-48DE-BBD9-4386BDBD3DA2"><gtr:id>E2B51889-99D4-48DE-BBD9-4386BDBD3DA2</gtr:id><gtr:title>IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/b16629f7643a0249636b4dc0eb514bb4"><gtr:id>b16629f7643a0249636b4dc0eb514bb4</gtr:id><gtr:otherNames>Verri WA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/96ACA6B8-BCF3-4A08-9CAE-972C30569A94"><gtr:id>96ACA6B8-BCF3-4A08-9CAE-972C30569A94</gtr:id><gtr:title>An interleukin-33/ST2 signaling deficiency reduces overt pain-like behaviors in mice.</gtr:title><gtr:parentPublicationTitle>Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9610041be7243589a3de52ccc8754eb4"><gtr:id>9610041be7243589a3de52ccc8754eb4</gtr:id><gtr:otherNames>Magro DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0100-879X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/615EDB88-5BF6-4B0B-A685-6659DC2495D4"><gtr:id>615EDB88-5BF6-4B0B-A685-6659DC2495D4</gtr:id><gtr:title>Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6e229b7f89cf01dfcc9d17eeeea2f9b9"><gtr:id>6e229b7f89cf01dfcc9d17eeeea2f9b9</gtr:id><gtr:otherNames>Raggatt LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E9A263AD-EBBB-42B1-B0DC-4ECAC821BDE5"><gtr:id>E9A263AD-EBBB-42B1-B0DC-4ECAC821BDE5</gtr:id><gtr:title>IL-33 exacerbates antigen-induced arthritis by activating mast cells.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e8d926f151e1a5ca9c91291369227789"><gtr:id>e8d926f151e1a5ca9c91291369227789</gtr:id><gtr:otherNames>Xu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1E3CBDB3-F409-40EA-8C10-214032EE863E"><gtr:id>1E3CBDB3-F409-40EA-8C10-214032EE863E</gtr:id><gtr:title>Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ca52db21e71dca00b7f92f38da2e47e"><gtr:id>8ca52db21e71dca00b7f92f38da2e47e</gtr:id><gtr:otherNames>McKimmie CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C0EA16E9-895D-42FC-A3AC-F8EAE62761F4"><gtr:id>C0EA16E9-895D-42FC-A3AC-F8EAE62761F4</gtr:id><gtr:title>IL-33/ST2 signalling contributes to carrageenin-induced innate inflammation and inflammatory pain: role of cytokines, endothelin-1 and prostaglandin E2.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8c67da887a938fbf22b16b3305eeaf91"><gtr:id>8c67da887a938fbf22b16b3305eeaf91</gtr:id><gtr:otherNames>Zarpelon AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/47F52BF7-E022-4AF1-8428-40D065738820"><gtr:id>47F52BF7-E022-4AF1-8428-40D065738820</gtr:id><gtr:title>The IL-33/ST2 pathway--A new therapeutic target in cardiovascular disease.</gtr:title><gtr:parentPublicationTitle>Pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fdcdecde1e6b0fc0dca13d046b13fffe"><gtr:id>fdcdecde1e6b0fc0dca13d046b13fffe</gtr:id><gtr:otherNames>Miller AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0163-7258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8D776D4A-8CC4-455C-A08A-E72286725E2B"><gtr:id>8D776D4A-8CC4-455C-A08A-E72286725E2B</gtr:id><gtr:title>IL-18 is a key proximal mediator of contact hypersensitivity and allergen-induced Langerhans cell migration in murine epidermis.</gtr:title><gtr:parentPublicationTitle>Journal of leukocyte biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a0a78a7073973b04b5a98bc64e325a2f"><gtr:id>a0a78a7073973b04b5a98bc64e325a2f</gtr:id><gtr:otherNames>Antonopoulos C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0741-5400</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BB7FBAC0-B233-465D-934C-AA7E4B1022BE"><gtr:id>BB7FBAC0-B233-465D-934C-AA7E4B1022BE</gtr:id><gtr:title>IL-33 is a chemoattractant for human Th2 cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/63e638ecaaad0ff3875bc715972a1fc2"><gtr:id>63e638ecaaad0ff3875bc715972a1fc2</gtr:id><gtr:otherNames>Komai-Koma M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90B246F0-9976-4947-81F8-298A62CDAFF7"><gtr:id>90B246F0-9976-4947-81F8-298A62CDAFF7</gtr:id><gtr:title>IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/27d6c70628e2e918f4cbee0dcadac415"><gtr:id>27d6c70628e2e918f4cbee0dcadac415</gtr:id><gtr:otherNames>Niedbala W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/76F2E3E9-37C0-454B-B0F8-00650B1A16C6"><gtr:id>76F2E3E9-37C0-454B-B0F8-00650B1A16C6</gtr:id><gtr:title>Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8ca52db21e71dca00b7f92f38da2e47e"><gtr:id>8ca52db21e71dca00b7f92f38da2e47e</gtr:id><gtr:otherNames>McKimmie CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A3D528AC-E5FB-4685-9051-EF4E6645B6BD"><gtr:id>A3D528AC-E5FB-4685-9051-EF4E6645B6BD</gtr:id><gtr:title>Galectin-3 deficiency reduces the severity of experimental autoimmune encephalomyelitis.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f2a2fc1758d2867fc19fb4fd882fa28f"><gtr:id>f2a2fc1758d2867fc19fb4fd882fa28f</gtr:id><gtr:otherNames>Jiang HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DC4BCB1E-077A-4F87-A816-E66635A93705"><gtr:id>DC4BCB1E-077A-4F87-A816-E66635A93705</gtr:id><gtr:title>IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d6382940be00966049fbb664f03fba32"><gtr:id>d6382940be00966049fbb664f03fba32</gtr:id><gtr:otherNames>Turnquist HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9818261</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>